Recombinant Chicken Cadherin-1 (CDH1)

What is Recombinant Chicken Cadherin-1 (CDH1)?

Recombinant Chicken Cadherin-1 is a laboratory-produced version of the native chicken E-cadherin protein, typically expressed in bacterial systems such as E. coli. CDH1 is a transmembrane glycoprotein that belongs to the classical cadherin superfamily and is essential for tissue integrity and cell-to-cell communication in chicken tissues. It plays a critical role in the development and maintenance of epithelial sheets through calcium-dependent adhesion mechanisms. The recombinant version allows researchers to study the protein's functions in controlled experimental settings without the need for direct tissue extraction .

In commercial forms, recombinant CDH1 is often produced with tags (such as N-terminal histidine tags) to facilitate purification and detection. These tagged versions maintain the functional domains necessary for experimental applications while enabling easier handling and analysis .

What are the key specifications of commercially available Recombinant Chicken Cadherin-1?

Commercially available Recombinant Chicken CDH1 typically comes with the following specifications:

The recombinant protein is typically shipped on dry ice and should be stored at -80°C upon receipt for optimal stability .

What is the biological function of Cadherin-1 in chicken development?

Chicken Cadherin-1 (CDH1) serves multiple critical functions during avian development:

• Epithelial Integrity: CDH1 is essential for maintaining the structural integrity of epithelial tissues in multiple organs.

• Cellular Adhesion: As a calcium-dependent adhesion molecule, it creates strong bonds between adjacent cells, forming adherens junctions that are vital for tissue stability.

• Tissue Organization: CDH1 helps establish and maintain proper tissue architecture during embryonic development.

• Signaling Regulation: Beyond its structural role, CDH1 participates in regulating cellular signaling pathways that control development, differentiation, and potentially disease processes including cancer .

Unlike other cadherins such as N-cadherin (which is expressed in neural tissues, endothelial cells, and cardiac myocytes) or protocadherin-1 (which functions in neural crest cell localization to the dorsal root ganglia), CDH1 primarily maintains epithelial cohesion and organization .

How can researchers differentiate between the functions of CDH1 and other cadherin family members?

Differentiating between cadherin family members requires careful experimental design due to their structural similarities but distinct expression patterns and functions:

• Expression Mapping Comparison: In the developing chicken embryo, eight classic cadherins show highly differential expression patterns. While CDH1 localizes primarily to epithelial tissues, other cadherins show specific patterns: cadherin-6B expresses in hair cells and spindle-shaped cells, cadherin-8 is found in supporting cells, and N-cadherin appears in sensory epithelium and acoustic ganglion neurons .

• Functional Domain Analysis: Researchers can construct domain-swapping experiments where the extracellular, transmembrane, or cytoplasmic domains of CDH1 are exchanged with those from other cadherins to determine which regions confer specific functionalities.

• Temporal Expression Studies: Monitoring the temporal dynamics of different cadherin expressions can reveal their sequential roles. For example, protocadherin-1 expression in the peripheral nervous system becomes discernible at stage 17 in chicken embryos, while other cadherins follow different developmental timelines .

• Co-immunoprecipitation Studies: These can identify binding partners specific to each cadherin type, clarifying their unique downstream signaling pathways and cellular functions.

The distinct expression patterns in tissue-specific contexts provide powerful evidence for the non-redundant roles of different cadherin family members .

What experimental approaches can be used to study CDH1 function in chicken embryonic development?

Several sophisticated approaches can be employed to study CDH1 function during chicken embryonic development:

• In Ovo Electroporation: This technique allows for targeted gene delivery to specific regions of the developing embryo. For CDH1 studies, researchers can introduce expression vectors, dominant-negative constructs, or siRNAs to manipulate CDH1 levels in specific tissues.

• Dominant-Negative Strategies: Similar to approaches used with protocadherins, constructs lacking the extracellular domain of CDH1 can function as potent dominant negatives, disrupting endogenous CDH1 function while maintaining the intracellular interactions .

• Ex Ovo Embryo Culture: This allows for direct manipulation and visualization of CDH1 activity in developing tissues while maintaining proper environmental conditions.

• Tissue-Specific Expression Analysis: In situ hybridization and immunolocalization studies can map the precise spatiotemporal expression of CDH1 across developmental stages, as has been done with other cadherins in the chicken cochlea development model .

• Functional Blocking Experiments: Antibodies that specifically recognize the extracellular domain of CDH1 can be used to block its adhesive functions without affecting protein expression levels.

These methodologies allow researchers to dissect both the structural and signaling roles of CDH1 in developing tissues .

How does CDH1 expression compare with other cadherins in chicken tissue development?

Comparative analysis of cadherin expression during chicken embryonic development reveals distinct spatiotemporal patterns that suggest specialized functions:

These differential expression patterns highlight the functional specialization of cadherin family members during development. While CDH1 maintains epithelial integrity, other cadherins like N-cadherin facilitate neural connections, and protocadherin-1 regulates neural crest cell distribution between dorsal root ganglia and sympathetic ganglia .

What are the optimal storage and handling conditions for Recombinant Chicken Cadherin-1?

Proper storage and handling of Recombinant Chicken CDH1 is critical for maintaining protein activity and experimental reproducibility:

• Long-term Storage: Store lyophilized protein at -80°C upon receipt. Reconstituted protein solution should be stored at 4°C for up to 1 week or at -80°C for up to 12 months .

• Reconstitution Protocol:

  • Always centrifuge tubes before opening to collect material at the bottom

  • Avoid mixing by vortexing or excessive pipetting

  • Reconstitute in 10mM PBS (pH 7.4) to a concentration of 0.1-1.0 mg/mL

  • Create small aliquots to minimize freeze-thaw cycles

• Working with Reconstituted Protein:

  • Thaw aliquots at 4°C or on ice

  • Use within the same day once thawed

  • Keep on ice during experiments

  • Avoid repeated freeze-thaw cycles which can cause protein denaturation

• Temperature Considerations: Temperature fluctuations should be minimized. For shipping and transport between laboratories, dry ice is recommended to maintain appropriate temperatures .

Following these guidelines will help ensure the stability and activity of the recombinant protein in experimental applications.

How can researchers validate the functionality of Recombinant Chicken Cadherin-1 in experiments?

Validating the functionality of Recombinant Chicken CDH1 is essential before proceeding with complex experiments. Several approaches can be employed:

• Adhesion Assays: Since CDH1 mediates cell-cell adhesion, researchers can coat plates with the recombinant protein and measure the adhesion of appropriate cell types. Calcium-dependent binding would indicate functional protein.

• Western Blotting with Conformation-Specific Antibodies: Some antibodies recognize only properly folded CDH1, which can help confirm the recombinant protein maintains its native conformation.

• Binding Partner Co-Immunoprecipitation: CDH1 interacts with specific intracellular proteins like β-catenin. Demonstrating these interactions through co-IP experiments helps validate protein functionality.

• Calcium Binding Assays: As a calcium-dependent adhesion molecule, functional CDH1 should demonstrate calcium binding, which can be measured through various biophysical methods.

• Cell Culture Rescue Experiments: In cells where endogenous CDH1 has been knocked down, introducing functional recombinant CDH1 should rescue the adhesion phenotype.

Positive results in these assays would confirm that the recombinant protein maintains the functional characteristics of native CDH1 and is suitable for further experiments.

What protocols can be used to analyze tissue-specific expression of CDH1 in chicken embryonic development?

To effectively analyze the tissue-specific expression of CDH1 during chicken embryonic development, researchers can employ multiple complementary techniques:

• Whole-mount In Situ Hybridization:

  • This technique allows visualization of mRNA expression patterns in intact embryos

  • Can be performed at multiple developmental stages to track temporal changes

  • Similar to the approach used for other cadherins in the chicken cochlea

• Immunolocalization:

  • Generate or obtain specific antibodies against chicken CDH1

  • Process embryos at various developmental stages

  • Use fluorescent secondary antibodies for visualization with confocal microscopy

  • Can be combined with markers for cell proliferation or differentiation

• Section Analysis:

  • After whole-mount procedures, embryos can be sectioned to reveal the precise cellular localization

  • Transverse sections are particularly informative for analyzing expression in neural structures

  • Allows co-localization with other markers on the same tissue section

• Quantitative Real-time PCR:

  • For precise quantification of CDH1 expression levels in dissected tissues

  • Can compare expression levels across developmental stages

  • Requires careful selection of reference genes for normalization

These methods have been successfully applied to study the expression of related cadherins in chicken embryos and can be adapted for CDH1-specific analysis .

What are common challenges in experiments using Recombinant Chicken Cadherin-1?

Researchers working with Recombinant Chicken CDH1 may encounter several challenges that can impact experimental outcomes:

• Protein Aggregation: Cadherins have a tendency to aggregate, particularly at higher concentrations or after multiple freeze-thaw cycles. This can be mitigated by:

  • Including low concentrations of detergents like Sarcosyl (0.01%) in storage buffers

  • Adding reducing agents such as DTT (1 mM) to prevent disulfide-mediated aggregation

  • Using stabilizers like Trehalose (5%) to maintain protein conformation

• Calcium Sensitivity: As calcium-dependent adhesion molecules, cadherins require proper calcium concentrations for function:

  • Too little calcium may result in loss of functional conformation

  • Calcium must be present in experimental buffers at physiological concentrations

  • EDTA and other calcium chelators should be avoided in working solutions

• Tag Interference: The N-terminal His-tag used for purification may sometimes interfere with function:

  • Consider enzymatic removal of the tag for sensitive functional assays

  • Compare tagged and untagged versions in critical experiments

  • Ensure the tag does not mask important functional domains

• Specificity Issues in Complex Systems: When studying CDH1 in tissues expressing multiple cadherins, specific detection can be challenging:

  • Use highly specific antibodies validated for chicken CDH1

  • Consider using knockout/knockdown controls to validate specificity

  • Design experiments to differentiate between cadherin family members

Addressing these challenges through careful experimental design and controls will enhance the reliability of results obtained with recombinant CDH1.

What controls should be included in experiments using Recombinant Chicken Cadherin-1?

Rigorous experimental design requires appropriate controls when working with Recombinant Chicken CDH1:

• Protein Controls:

  • Denatured CDH1 protein (heat-treated) to control for non-specific effects

  • Calcium-free conditions to demonstrate calcium dependence of observed effects

  • Concentration gradients to establish dose-response relationships

  • Alternative cadherins (e.g., N-cadherin) to assess specificity of observed effects

• Antibody Controls (for detection experiments):

  • Pre-immune serum controls

  • Isotype controls for immunohistochemistry

  • Secondary antibody-only controls

  • Peptide competition assays to confirm antibody specificity

• Expression Controls:

  • In development studies, examine tissue regions known to be positive or negative for CDH1

  • Include analysis of housekeeping genes for normalization

  • For comparative studies, analyze multiple cadherins in parallel to establish expression patterns

• Functional Controls:

  • Function-blocking antibodies against CDH1 to confirm specific activity

  • Dominant-negative constructs (especially those lacking extracellular domains)

  • Rescue experiments to confirm specificity of observed phenotypes